SNU13

Across TCGA pan-cancer cohorts, SNU13 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SNU13 data layer compared with 25 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SNU13 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SNU13 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

COAD, CCRCC, and PDAC are the cancer types where SNU13 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.920	.014	30	view →
CCRCC	DFS	Median	All	0.855	0.980	.002	22	view →
PDAC	DFS	Median	All	0.825	0.698	.004	18	view →
LUAD	DFS	Median	All	0.769	0.476	.006	18	view →
HNSC	OS	Quartile	IV	0.759	0.978	.012	13	view →
GBM	OS	Median	All	0.675	0.408	.004	7	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SNU13–COAD (DFS)

Open the COAD breakdown →